Since the establishment several decades ago, CSPC has been growing, innovating and progressing, and achieved leaping development and gratifying achievements, and successively won the honorable titles of "Advanced Collective of Chinese Pharmaceutical Industry", "Advanced Enterprise in Quality and Efficiency", "Manufacturer with Assured Product Quality", "National May 1st Labor Award", "Environment Loving Enterprise of China", etc.
On the regard of R&D, CSPC has successively developed over 90 national-level new drugs relying on its "post-doctoral mobile research center", "National-level Enterprise Technical Center", "863 Program" High-tech Industrialization Base and Hebei Provincial Preparation Engineering Technical Center in recent years, involving a great variety of fields such as biotechnology, chiral synthetic drugs, liposome, transdermal preparation, molecular microcapsules, etc.
To date, CSPC Pharma.has applied for 200 patents, including more than 10 PCT international patents.
In terms of quality, CSPC Pharma.has established a self-contained three-level quality control system, and all the drugs have achieved GMP certification, and all the subordinated companies have passed ISO9000, OHSAS18000 and ISO14001 certifications, and the up-to-standard rate of the products has been kept at 100% constantly in the market.
To speed actual data transmission, CSPC significantly improves mainframe-to-PC response time by minimizing the amount of screen display data.
Another benefit of CSPC is that it provides the same look and feel to end-users wherever they are located.
While we expect to see increased remote access for international sites, at present the major end-user depending on CSPC is our U.S.-based Truck Engine Parts Service (TEPS) dealers.
